{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:39:28Z","timestamp":1791920368442,"version":"4.3.4"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiological Methods"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.mimet.2025.107138","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T16:56:24Z","timestamp":1745427384000},"page":"107138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Current advancements in nanoparticles for vaccines and drug delivery for the treatment of tuberculosis"],"prefix":"10.1016","volume":"232-234","author":[{"given":"Dinesh Kumar","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.mimet.2025.107138_bb0005","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1469-0691.2004.00758.x","article-title":"Tuberculosis in HIV-infected patients: a comprehensive review","volume":"10","author":"Aaron","year":"2004","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.mimet.2025.107138_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1556-276X-9-247","article-title":"Dendrimers: synthesis, applications, and properties","volume":"9","author":"Abbasi","year":"2014","journal-title":"Nanoscale Res. Lett."},{"issue":"2","key":"10.1016\/j.mimet.2025.107138_bb0015","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2567.2007.02751.x","article-title":"Adjuvant modulation of the cytokine balance in Mycobacterium tuberculosis subunit vaccines; immunity, pathology and protection","volume":"124","author":"Agger","year":"2008","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.mimet.2025.107138_bb0020","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ijantimicag.2005.12.009","article-title":"Pharmacokinetic and pharmacodynamic behaviour of antitubercular drugs encapsulated in alginate nanoparticles at two doses","volume":"27","author":"Ahmad","year":"2006","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"3","key":"10.1016\/j.mimet.2025.107138_bb0025","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jpba.2008.02.006","article-title":"Effect of \u03b2-cyclodextrin and hydroxypropyl \u03b2-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir","volume":"47","author":"Aleem","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.mimet.2025.107138_bb0030","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1517\/17425247.3.1.139","article-title":"Polymeric micelles for drug delivery","volume":"3","author":"Aliabadi","year":"2006","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.mimet.2025.107138_bb0035","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4103\/1817-1737.44778","article-title":"Diagnosis of latent tuberculosis: can we do better?","volume":"4","author":"Al-Orainey","year":"2009","journal-title":"Ann. Thoracic Med."},{"issue":"1","key":"10.1016\/j.mimet.2025.107138_bb0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12088-023-01061-0","article-title":"Novel biocompatible green silver nanoparticles efficiently eliminates multidrug resistant nosocomial pathogens and mycobacterium species","volume":"63","author":"Aman","year":"2023","journal-title":"Indian J. Microbiol."},{"issue":"1\u20132","key":"10.1016\/j.mimet.2025.107138_bb0045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jconrel.2005.11.014","article-title":"Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system","volume":"111","author":"Amidi","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.mimet.2025.107138_bb0050","article-title":"The influence of nanoparticulate drug delivery systems in drug therapy","volume":"60","author":"Aminu","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.mimet.2025.107138_bb0055","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1023\/A:1010061013365","article-title":"Nanoparticles as antituberculosis drugs carriers: effect on activity against Mycobacterium tuberculosis in human monocyte-derived macrophages","volume":"2","author":"Anisimova","year":"2000","journal-title":"J. Nanopart. Res."},{"issue":"40","key":"10.1016\/j.mimet.2025.107138_bb0060","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.1016\/j.vaccine.2011.07.039","article-title":"Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis","volume":"29","author":"Ballester","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.mimet.2025.107138_bb0065","doi-asserted-by":"crossref","first-page":"2000113","DOI":"10.1002\/adtp.202000113","article-title":"Nanotechnology-based targeted drug delivery: an emerging tool to overcome tuberculosis","volume":"4","author":"Baranyai","year":"2021","journal-title":"Adv. Therap."},{"key":"10.1016\/j.mimet.2025.107138_bb0070","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jmgm.2015.05.012","article-title":"Association of the anti-tuberculosis drug rifampicin with a PAMAM dendrimer","volume":"60","author":"Bellini","year":"2015","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.mimet.2025.107138_bb0075","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10875-007-9084-0","article-title":"Host innate immune response to Mycobacterium tuberculosis","volume":"27","author":"Bhatt","year":"2007","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.mimet.2025.107138_bb0080","article-title":"Late stage specific Rv0109 (PE_PGRS1) protein of Mycobacterium tuberculosis induces mitochondria mediated macrophage apoptosis","volume":"176","author":"Bhatt","year":"2023","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.mimet.2025.107138_bb0085","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s11095-016-1958-5","article-title":"Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date","volume":"33","author":"Bobo","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.mimet.2025.107138_bb0090","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejpb.2016.12.019","article-title":"Polymeric mixed micelles as nanomedicines: achievements and perspectives","volume":"113","author":"Cagel","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1\u20132","key":"10.1016\/j.mimet.2025.107138_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2010.12.040","article-title":"Influence of particle size on regional lung deposition\u2013what evidence is there?","volume":"406","author":"Carvalho","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.mimet.2025.107138_bb0100","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1021\/acs.molpharmaceut.1c00447","article-title":"Lipid-based nanoparticles for delivery of vaccine adjuvants and antigens: toward multicomponent vaccines","volume":"18","author":"Chatzikleanthous","year":"2021","journal-title":"Mol. Pharm."},{"issue":"12","key":"10.1016\/j.mimet.2025.107138_bb0105","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1080\/03639045.2018.1506472","article-title":"Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis","volume":"44","author":"Chokshi","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"2","key":"10.1016\/j.mimet.2025.107138_bb0110","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/jps.22284","article-title":"Vaccines with aluminum-containing adjuvants: optimizing vaccine efficacy and thermal stability","volume":"100","author":"Clapp","year":"2011","journal-title":"J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.mimet.2025.107138_bb0115","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.addr.2007.10.013","article-title":"Advances in lipid nanodispersions for parenteral drug delivery and targeting","volume":"60","author":"Constantinides","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.mimet.2025.107138_bb0120","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.addr.2008.09.005","article-title":"Nanoparticles for nasal vaccination","volume":"61","author":"Csaba","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.mimet.2025.107138_bb0125","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1166\/jbn.2016.2149","article-title":"Nanotechnology-based drug delivery systems for treatment of tuberculosis: a review","volume":"12","author":"Da Silva","year":"2016","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.mimet.2025.107138_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.mimet.2020.106127","article-title":"Nano-based drug delivery optimization for tuberculosis treatment: A review","volume":"181","author":"Dahanayake","year":"2021","journal-title":"J. Microbiol. Methods"},{"issue":"6","key":"10.1016\/j.mimet.2025.107138_bb0135","first-page":"826","article-title":"A novel formulation of Mtb72F DNA vaccine for immunization against tuberculosis","volume":"23","author":"Dalirfardouei","year":"2020","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"2","key":"10.1016\/j.mimet.2025.107138_bb0140","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1183\/09031936.00007814","article-title":"Xpert MTB\/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis","volume":"44","author":"Denkinger","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.mimet.2025.107138_bb0145","first-page":"835","article-title":"Vaccine delivery system for tuberculosis based on nano-sized hepatitis B virus core protein particles","volume":"25","author":"Dhanasooraj","year":"2013","journal-title":"Int. J. Nanomedicine"},{"issue":"3","key":"10.1016\/j.mimet.2025.107138_bb0150","doi-asserted-by":"crossref","DOI":"10.3310\/hta11030","article-title":"A systematic review of rapid diagnostic tests for the detection of tuberculosis infection","volume":"11","author":"Dinnes","year":"2007","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.mimet.2025.107138_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1465-9921-7-118","article-title":"Tuberculosis chemotherapy: current drug delivery approaches","volume":"7","author":"Du Toit","year":"2006","journal-title":"Respir. Res."},{"issue":"3","key":"10.1016\/j.mimet.2025.107138_bb0160","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1039\/C6SC03631G","article-title":"Immunological properties of gold nanoparticles","volume":"8","author":"Dykman","year":"2017","journal-title":"Chem. Sci."},{"issue":"1\u20132","key":"10.1016\/j.mimet.2025.107138_bb0165","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijpharm.2006.09.017","article-title":"Biological evaluation of pyrazinamide liposomes for treatment of Mycobacterium tuberculosis","volume":"330","author":"El-Ridy","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.mimet.2025.107138_bb0170","first-page":"43","article-title":"Analysis of the molecular association of rifampicin with hydroxypropyl-2-cyclodextrin","volume":"40","author":"Ferreira","year":"2004","journal-title":"Rev. Brasil. Ci\u00ean. Farmac\u00eaut."},{"issue":"24","key":"10.1016\/j.mimet.2025.107138_bb0175","doi-asserted-by":"crossref","first-page":"13225","DOI":"10.1002\/anie.202010282","article-title":"Biopolymer-based carriers for DNA vaccine design","volume":"60","author":"Franck","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1","key":"10.1016\/j.mimet.2025.107138_bb0180","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijantimicag.2007.08.008","article-title":"Rifabutin encapsulated in liposomes exhibits increased therapeutic activity in a model of disseminated tuberculosis","volume":"31","author":"Gaspar","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.mimet.2025.107138_bb0185","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.tube.2016.05.013","article-title":"TB vaccines in clinical development","volume":"99","author":"Ginsberg","year":"2016","journal-title":"Tuberculosis"},{"issue":"12","key":"10.1016\/j.mimet.2025.107138_bb0190","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1164\/rccm.201807-1318OC","article-title":"Amikacin liposome inhalation suspension for treatment-refractory lung disease caused by Mycobacterium avium complex (CONVERT). A prospective, open-label, randomized study","volume":"198","author":"Griffith","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.mimet.2025.107138_bb0195","article-title":"Cationic rifampicin nanoemulsion for the treatment of ocular tuberculosis","volume":"597","author":"Henostroza","year":"2020","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"issue":"4","key":"10.1016\/j.mimet.2025.107138_bb0200","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/mi.2012.19","article-title":"Mechanisms of delayed anti-tuberculosis protection in the lung of parenteral BCG-vaccinated hosts: a critical role of airway luminal T cells","volume":"5","author":"Horvath","year":"2012","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.mimet.2025.107138_bb0205","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2147\/IJN.S236277","article-title":"Novel approach for transdermal delivery of rifampicin to induce synergistic antimycobacterial effects against cutaneous and systemic tuberculosis using a cationic nanoemulsion gel","volume":"14","author":"Hussain","year":"2020","journal-title":"Int. J. Nanomedicine"},{"issue":"3","key":"10.1016\/j.mimet.2025.107138_bb0210","doi-asserted-by":"crossref","first-page":"834","DOI":"10.2214\/AJR.07.3896","article-title":"Pulmonary tuberculosis: up-to-date imaging and management","volume":"191","author":"Jeong","year":"2008","journal-title":"Am. J. Roentgenol."},{"issue":"4","key":"10.1016\/j.mimet.2025.107138_bb0215","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3109\/10408440903453074","article-title":"A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity","volume":"40","author":"Johnston","year":"2010","journal-title":"Crit. Rev. Toxicol."},{"issue":"1","key":"10.1016\/j.mimet.2025.107138_bb0220","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1080\/21505594.2021.1990660","article-title":"Insights into the molecular determinants involved in Mycobacterium tuberculosis persistence and their therapeutic implications","volume":"12","author":"Joshi","year":"2021","journal-title":"Virulence"},{"key":"10.1016\/j.mimet.2025.107138_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.mseb.2023.116816","article-title":"Trends in smart drug delivery systems for targeting cancer cells","volume":"297","author":"Kandula","year":"2023","journal-title":"Mater. Sci. Eng. B"},{"issue":"2","key":"10.1016\/j.mimet.2025.107138_bb0230","first-page":"224","article-title":"Preparation, characterization and tissue disposition of niosomes containing isoniazid","volume":"1","author":"Karki","year":"2008","journal-title":"Rasayan J. Chem."},{"issue":"8","key":"10.1016\/j.mimet.2025.107138_bb0235","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1473-3099(11)70146-3","article-title":"Fact and fiction in tuberculosis vaccine research: 10 years later","volume":"11","author":"Kaufmann","year":"2011","journal-title":"Lancet Infect. Dis."},{"issue":"2","key":"10.1016\/j.mimet.2025.107138_bb0240","first-page":"116","article-title":"Potential of polymeric particles as future vaccine delivery systems\/adjuvants for parenteral and non-parenteral immunization against tuberculosis: A systematic review","volume":"21","author":"Khademi","year":"2018","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.mimet.2025.107138_bb0245","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.colsurfa.2019.01.004","article-title":"Formulation and optimization of long acting dual niosomes using box-Behnken experimental design method for combinative delivery of ethionamide and D-cycloserine in tuberculosis treatment","volume":"565","author":"Kulkarni","year":"2019","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"issue":"8","key":"10.1016\/j.mimet.2025.107138_bb0250","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1080\/10611860600825159","article-title":"Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers","volume":"14","author":"Kumar","year":"2006","journal-title":"J. Drug Target."},{"issue":"8","key":"10.1016\/j.mimet.2025.107138_bb0255","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1089\/dna.2007.0693","article-title":"The synthetic antimicrobial peptide KLKL5KLK enhances the protection and efficacy of the combined DNA vaccine against Mycobacterium tuberculosis","volume":"27","author":"Li","year":"2008","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.mimet.2025.107138_bb0260","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.csbj.2015.11.001","article-title":"Self-assembling protein nanoparticles in the design of vaccines","volume":"14","author":"L\u00f3pez-Sagaseta","year":"2016","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"1","key":"10.1016\/j.mimet.2025.107138_bb0265","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1080\/10717544.2022.2120565","article-title":"Nanomaterials in tuberculosis DNA vaccine delivery: historical perspective and current landscape","volume":"29","author":"Luo","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.mimet.2025.107138_bb0270","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cis.2012.08.002","article-title":"Niosomes: novel sustained release nonionic stable vesicular systems\u2014an overview","volume":"183","author":"Mahale","year":"2012","journal-title":"Adv. Colloid Interf. Sci."},{"issue":"11","key":"10.1016\/j.mimet.2025.107138_bb0275","doi-asserted-by":"crossref","first-page":"6540","DOI":"10.1128\/AAC.00700-16","article-title":"Pulmonary deposition and elimination of liposomal amikacin for inhalation and effect on macrophage function after administration in rats","volume":"60","author":"Malinin","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.mimet.2025.107138_bb0280","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.colsurfb.2012.07.006","article-title":"Formulation of Tyloxapol niosomes for encapsulation, stabilization and dissolution of anti-tubercular drugs","volume":"101","author":"Mehta","year":"2013","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"1","key":"10.1016\/j.mimet.2025.107138_bb0285","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.colsurfb.2011.05.018","article-title":"Quantitative investigation, stability and in vitro release studies of anti-TB drugs in Triton niosomes","volume":"87","author":"Mehta","year":"2011","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"3","key":"10.1016\/j.mimet.2025.107138_bb0290","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/pharmaceutics10030105","article-title":"New ways to treat tuberculosis using dendrimers as nanocarriers","volume":"10","author":"Mignani","year":"2018","journal-title":"Pharmaceutics"},{"issue":"17","key":"10.1016\/j.mimet.2025.107138_bb0295","doi-asserted-by":"crossref","first-page":"9652","DOI":"10.3390\/ijms22179652","article-title":"Advances in chitosan-based nanoparticles for drug delivery","volume":"22","author":"Miku\u0161ov\u00e1","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6\u20138","key":"10.1016\/j.mimet.2025.107138_bb0300","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.imbio.2006.06.004","article-title":"Modulation of macrophage antimicrobial mechanisms by pathogenic mycobacteria","volume":"211","author":"Mueller","year":"2006","journal-title":"Immunobiology"},{"key":"10.1016\/j.mimet.2025.107138_bb0305","series-title":"Nanotechnology-Based Approach in Tuberculosis Treatment. Tuberculosis Research and Treatment","author":"Nasiruddin","year":"2017"},{"issue":"1\u20132","key":"10.1016\/j.mimet.2025.107138_bb0310","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ijpharm.2013.11.023","article-title":"PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization","volume":"461","author":"Nasr","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.mimet.2025.107138_bb0315","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1164\/rccm.201604-0700OC","article-title":"Randomized trial of liposomal amikacin for inhalation in nontuberculous mycobacterial lung disease","volume":"195","author":"Olivier","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.mimet.2025.107138_bb0320","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3201\/eid1402.071411","article-title":"Encyclopedia of infectious diseases: modern methodologies","volume":"14","author":"Ostroff","year":"2008","journal-title":"Emerg. Infect. Dis."},{"issue":"1","key":"10.1016\/j.mimet.2025.107138_bb0325","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owens","year":"2006","journal-title":"Int. J. Pharm."},{"issue":"5\u20136","key":"10.1016\/j.mimet.2025.107138_bb0330","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.tube.2005.08.009","article-title":"Oral solid lipid nanoparticle-based antitubercular chemotherapy","volume":"85","author":"Pandey","year":"2005","journal-title":"Tuberculosis"},{"issue":"2","key":"10.1016\/j.mimet.2025.107138_bb0335","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/CMR.00059-10","article-title":"Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities","volume":"24","author":"Parsons","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"issue":"2","key":"10.1016\/j.mimet.2025.107138_bb0340","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ijpharm.2014.12.009","article-title":"Pulmonary drug delivery systems for tuberculosis treatment","volume":"478","author":"Pham","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.mimet.2025.107138_bb0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2010.03.017","article-title":"Formulation strategy and use of excipients in pulmonary drug delivery","volume":"392","author":"Pilcer","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.mimet.2025.107138_bb0350","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2217\/nnm.11.122","article-title":"Liposomes as drug delivery systems for the treatment of TB","volume":"6","author":"Pinheiro","year":"2011","journal-title":"Nanomedicine"},{"issue":"7","key":"10.1016\/j.mimet.2025.107138_bb0355","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1164\/rccm.201002-0310OC","article-title":"Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems","volume":"182","author":"Prevots","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"10","key":"10.1016\/j.mimet.2025.107138_bb0360","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1080\/10837450.2023.2279691","article-title":"Review of inhalable nanoparticles for the pulmonary delivery of anti-tuberculosis drugs","volume":"28","author":"Ramachandran","year":"2023","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.mimet.2025.107138_bb0365","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2147\/CCID.S39559","article-title":"Utilization of biodegradable polymeric materials as delivery agents in dermatology","volume":"9","author":"Rancan","year":"2014","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"10.1016\/j.mimet.2025.107138_bb0370","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1208\/s12249-018-1151-8","article-title":"Smartly engineered PEGylated di-block nanopolymeric micelles: duo delivery of isoniazid and rifampicin against Mycobacterium tuberculosis","volume":"19","author":"Rani","year":"2018","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.mimet.2025.107138_bb0375","first-page":"37","article-title":"Balasangameshwer, physicochemical characterization of \u03b2-cyclodextrin and hydroxy ethyl \u03b2-cyclodextrin complexes of rifampicin","volume":"47","author":"Rao","year":"2006","journal-title":"Ars Pharm."},{"issue":"1","key":"10.1016\/j.mimet.2025.107138_bb0380","first-page":"1","article-title":"Nanotechnology-based drug delivery system for the diagnosis and treatment of ovarian cancer","volume":"16","author":"Saripilli","year":"2025","journal-title":"Discov. Oncol."},{"issue":"2","key":"10.1016\/j.mimet.2025.107138_bb0385","doi-asserted-by":"crossref","first-page":"148","DOI":"10.18433\/J33591","article-title":"An overview of tuberculosis chemotherapy\u2013a literature review","volume":"14","author":"Sarkar","year":"2011","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.mimet.2025.107138_bb0390","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/2051013614541440","article-title":"Liposomes as vaccine delivery systems: a review of the recent advances","volume":"2","author":"Schwendener","year":"2014","journal-title":"Therap. Adv. Vacc."},{"issue":"1","key":"10.1016\/j.mimet.2025.107138_bb0395","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1080\/10717544.2017.1384298","article-title":"Critical physicochemical and biological attributes of nanoemulsions for pulmonary delivery of rifampicin by nebulization technique in tuberculosis treatment","volume":"24","author":"Shah","year":"2017","journal-title":"Drug Deliv."},{"issue":"10","key":"10.1016\/j.mimet.2025.107138_bb0400","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s12098-020-03230-1","article-title":"Multi-drug resistant and extensively-drug resistant tuberculosis","volume":"87","author":"Shah","year":"2020","journal-title":"Ind. J. Pediatr."},{"key":"10.1016\/j.mimet.2025.107138_bb0405","first-page":"1","article-title":"Recent advances in medical applications of chitosan-based biomaterials","volume":"13","author":"Sharma","year":"2024","journal-title":"Int. J. Polym. Mater. Polym. Biomater."},{"issue":"3","key":"10.1016\/j.mimet.2025.107138_bb0410","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s12032-025-02609-4","article-title":"Recent advancements in nanoparticles for cancer treatment","volume":"42","author":"Sharma","year":"2025","journal-title":"Med. Oncol."},{"issue":"2","key":"10.1016\/j.mimet.2025.107138_bb0415","first-page":"14","article-title":"Nanotechnology-based drug delivery system in tuberculosis","volume":"3","author":"Sharma","year":"2017","journal-title":"Int.J. Nanobiotechnol."},{"issue":"13","key":"10.1016\/j.mimet.2025.107138_bb0420","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1080\/09205063.2022.2068947","article-title":"Preparation and in-vitro, in-vivo characterisation of pioglitazone loaded chitosan\/PEG blended PLGA biocompatible nanoparticles","volume":"33","author":"Sharma","year":"2022","journal-title":"J. Biomater. Sci. Polym. Ed."},{"issue":"9","key":"10.1016\/j.mimet.2025.107138_bb0425","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1080\/1061186X.2023.2261077","article-title":"Recent developments in nanoparticles for the treatment of diabetes","volume":"31","author":"Sharma","year":"2023","journal-title":"J. Drug Target."},{"issue":"24","key":"10.1016\/j.mimet.2025.107138_bb0430","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1016\/j.vaccine.2019.04.055","article-title":"Vaccine adjuvants: understanding the structure and mechanism of adjuvanticity","volume":"37","author":"Shi","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.mimet.2025.107138_bb0435","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s40265-019-01095-z","article-title":"Amikacin liposome inhalation suspension: a review in Mycobacterium avium complex lung disease","volume":"79","author":"Shirley","year":"2019","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.mimet.2025.107138_bb0440","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ardp.200500039","article-title":"Potential Tuberculostatic agent: micelle-forming pyrazinamide prodrug","volume":"339","author":"Silva","year":"2006","journal-title":"Arch. Pharm."},{"issue":"4","key":"10.1016\/j.mimet.2025.107138_bb0445","doi-asserted-by":"crossref","first-page":"815","DOI":"10.4314\/tjpr.v6i4.14665","article-title":"Preparation of polymeric micelles for use as carriers of tuberculostatic drugs","volume":"6","author":"Silva","year":"2007","journal-title":"Trop. J. Pharm. Res."},{"issue":"2","key":"10.1016\/j.mimet.2025.107138_bb0450","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4314\/tjpr.v10i2.66564","article-title":"Niosomal delivery of isoniazid-development and characterization","volume":"10","author":"Singh","year":"2011","journal-title":"Trop. J. Pharm. Res."},{"issue":"1","key":"10.1016\/j.mimet.2025.107138_bb0455","doi-asserted-by":"crossref","first-page":"6976","DOI":"10.1038\/s41598-023-32810-2","article-title":"Expedited diagnosis of pediatric tuberculosis using Truenat MTB-Rif dx and GeneXpert MTB\/RIF","volume":"13","author":"Singh","year":"2023","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.mimet.2025.107138_bb0460","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jconrel.2009.05.011","article-title":"Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination","volume":"138","author":"Sl\u00fctter","year":"2009","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.mimet.2025.107138_bb0465","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1039\/C4BM00202D","article-title":"Cellulose-based polyelectrolyte complex nanoparticles for DNA vaccine delivery","volume":"2","author":"Song","year":"2014","journal-title":"Biomater. Sci."},{"issue":"2","key":"10.1016\/j.mimet.2025.107138_bb0470","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/eji.201343887","article-title":"Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice","volume":"44","author":"Stylianou","year":"2014","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.mimet.2025.107138_bb0475","doi-asserted-by":"crossref","first-page":"e00088","DOI":"10.1128\/cmr.00088-23","article-title":"Micro-nanoemulsion and nanoparticle-assisted drug delivery against drug-resistant tuberculosis: recent developments","volume":"36","author":"Suman","year":"2023","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.mimet.2025.107138_bb0480","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bios.2016.08.084","article-title":"Point of care testing: the impact of nanotechnology","volume":"87","author":"Syedmoradi","year":"2017","journal-title":"Biosens. Bioelectron."},{"issue":"3","key":"10.1016\/j.mimet.2025.107138_bb0485","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jiac.2017.10.009","article-title":"Sensitivity and specificity of QuantiFERON-TB gold plus compared with QuantiFERON-TB gold in-tube and T-SPOT. TB on active tuberculosis in Japan","volume":"24","author":"Takasaki","year":"2018","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.mimet.2025.107138_bb0490","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tube.2018.07.003","article-title":"In vivo electroporation of a codon-optimized BERopt DNA vaccine protects mice from pathogenic Mycobacterium tuberculosis aerosol challenge","volume":"113","author":"Tang","year":"2018","journal-title":"Tuberculosis"},{"issue":"20","key":"10.1016\/j.mimet.2025.107138_bb0495","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.3390\/molecules24203744","article-title":"Biodegradable polymers for gene delivery","volume":"24","author":"Thomas","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.mimet.2025.107138_bb0500","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fimmu.2018.00310","article-title":"Formulation in DDA-MPLA-TDB liposome enhances the immunogenicity and protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection","volume":"9","author":"Tian","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.mimet.2025.107138_bb0505","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.nano.2016.08.031","article-title":"System with embedded drug release and nanoparticle degradation sensor showing efficient rifampicin delivery into macrophages","volume":"13","author":"Trousil","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.mimet.2025.107138_bb0510","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1007\/s11095-017-2206-3","article-title":"Conjugated and entrapped HPMA-PLA nano-polymeric micelles based dual delivery of first line anti TB drugs: improved and safe drug delivery against sensitive and resistant Mycobacterium tuberculosis","volume":"34","author":"Upadhyay","year":"2017","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.mimet.2025.107138_bb0515","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/21691401.2018.1559180","article-title":"Nano-rifabutin entrapment within glucan microparticles enhances protection against intracellular Mycobacterium tuberculosis","volume":"47","author":"Upadhyay","year":"2019","journal-title":"Art. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.mimet.2025.107138_bb0520","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ijbiomac.2022.12.087","article-title":"Current nanotechnological strategies using lipids, carbohydrates, proteins and metal conjugates-based carrier systems for diagnosis and treatment of tuberculosis\u2014A review","volume":"227","author":"Usharani","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.mimet.2025.107138_bb0525","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.cellbio.20.010403.114015","article-title":"Cell biology of Mycobacterium tuberculosis phagosome","volume":"20","author":"Vergne","year":"2004","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.mimet.2025.107138_bb0530","article-title":"Recent developments, challenges and future prospects in advanced drug delivery systems in the management of tuberculosis","volume":"75","author":"Verma","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.mimet.2025.107138_bb0535","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/156720107779314794","article-title":"PEGylated dendritic architecture for development of a prolonged drug delivery system for an antitubercular drug","volume":"4","author":"Vijayaraj Kumar","year":"2007","journal-title":"Curr. Drug Deliv."},{"issue":"8","key":"10.1016\/j.mimet.2025.107138_bb0540","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1080\/21645515.2015.1026499","article-title":"Alarmin IL-33 elicits potent TB-specific cell-mediated responses","volume":"11","author":"Villarreal","year":"2015","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.mimet.2025.107138_bb0545","first-page":"1","article-title":"Economic evaluation of patient costs associated with tuberculosis diagnosis and care in Solomon Islands","volume":"21","author":"Viney","year":"2021","journal-title":"BMC Public Health"},{"issue":"12","key":"10.1016\/j.mimet.2025.107138_bb0550","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1002\/jps.20728","article-title":"A practical approach to the use of nanoparticles for vaccine delivery","volume":"95","author":"Wendorf","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.mimet.2025.107138_bb0555","series-title":"WHO Operational Handbook on Tuberculosis. Module 3: Diagnosis-Rapid Diagnostics for Tuberculosis Detection","author":"World Health Organization","year":"2024"},{"key":"10.1016\/j.mimet.2025.107138_bb0560","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ces.2014.06.049","article-title":"Uniform biodegradable microparticle systems for controlled release","volume":"125","author":"Xia","year":"2015","journal-title":"Chem. Eng. Sci."},{"issue":"9","key":"10.1016\/j.mimet.2025.107138_bb0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023826","article-title":"Mycobacterium vaccae as adjuvant therapy to anti-tuberculosis chemotherapy in never-treated tuberculosis patients: a meta-analysis","volume":"6","author":"Yang","year":"2011","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.mimet.2025.107138_bb0570","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3390\/pharmaceutics12100911","article-title":"Advances in pulmonary drug delivery","volume":"12","author":"Y\u0131ld\u0131z-Pek\u00f6z","year":"2020","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.mimet.2025.107138_bb0575","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2174\/1568026615666150701114527","article-title":"Progress in self-assembling peptide-based nanomaterials for biomedical applications","volume":"16","author":"Yu","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.mimet.2025.107138_bb0580","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3389\/fmicb.2018.00915","article-title":"Amikacin liposome inhalation suspension (ALIS) penetrates non-tuberculous mycobacterial biofilms and enhances amikacin uptake into macrophages","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Microbiol."}],"container-title":["Journal of Microbiological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167701225000545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167701225000545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T13:28:06Z","timestamp":1749821286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167701225000545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":116,"alternative-id":["S0167701225000545"],"URL":"https:\/\/doi.org\/10.1016\/j.mimet.2025.107138","relation":{},"ISSN":["0167-7012"],"issn-type":[{"value":"0167-7012","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current advancements in nanoparticles for vaccines and drug delivery for the treatment of tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mimet.2025.107138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107138"}}